Perioperative novel systemic immunotherapy-based approaches in urinary cancers
Published: 9 Jun 2020
Views: 316
Dr Shilpa Gupta - Cleveland Clinic, Cleveland, USA
Dr Shilpa Gupta talks to ecancer in an online interview at the virtual ASCO meeting 2020 about the role of perioperative systemic immunotherapy in patients with urothelial cancer based on four abstracts.
The four trials are:
GU14-188 - Neoadjuvant gemcitabine and pembrolizumab prior to cystectomy in patients with cT2-4aN0M0 urothelial carcinoma.
NABUCCO - Neoadjuvant use of checkpoint inhibitor monotherapy (pembrolizumab or atezolizumab).
Neoadjuvant/adjuvant durvalumab with/without tremelimumab in renal cell carcinoma (RCC).
SWOG S1605 - Checkpoint inhibition using atezolizumab in Bacillus Calmette-Guérin (BCG) refractory nonmuscle-invasive bladder cancer.
Related Videos
Latest in bladder cancer with FGFR 2 and 3 mutations
Dr Yohann Loriot and Dr Scott Tagawa
24 Sep 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
24 Sep 2020
OncoAlert and ecancer weekly roundup for September 6-13, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
14 Sep 2020
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial c...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
30 Jun 2020
PARP inhibitors for metastatic breast cancer
Prof Michael Untch - Helios Hospital Berlin-Buch, Berlin, Germany
7 Oct 2019
Role of biomarkers, targeted therapy and tumour mutations in the landscape of bl...
Prof Petros Grivas and Dr Michiel Van der Heijden
30 Sep 2019
Targeted therapies in prostate cancer: Recent advances presented at ESMO 2019
Dr Eleni Efstathiou, Prof Noel Clarke, Dr Elena Castro, Prof Matthew Smith
30 Sep 2019
An overview of the latest advances in gastric cancer
Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
17 Jul 2019
ASCO GU 2019 renal highlights
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
14 Feb 2019
